Company Overview
SUTRO BIOPHARMA, INC.
STRORevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
102M
2025 FY
Net Income
-191M
2025 FY
Shares Outstanding
8M
2025 FY
EPS
-22.49USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1382101
Exchange
Nasdaq
Location
US